Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Study of the Effect of First-line Intraperitoneal Paclitaxel in Combination With SOX Versus SOX Alone in Gastric Cancer Patients With Malignant Ascites

NCT03475615 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT03475615
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03475615 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Study of the Effect of First-line Intraperitoneal Paclitaxel in Combination With SOX Versus SOX Alone in Gastric Cancer Patients With Malignant Ascites
Lead sponsor
Fudan University
Phase
Phase 3
Overall status
Unknown status
Start date
March 16, 2018
Completion date
December 31, 2020
Enrollment
215 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer, stomach neoplasms